Source: http://gooa.las.ac.cn/external/index?type=-1&pid=1465255
Timestamp: 2019-04-21 15:08:21+00:00

Document:
H. Horn, B. Böhme, L. Laura Dietrich, M. Koch. et al.(2018). Endocannabinoids in body weight control. Pharmaceuticals.11(2):55. DOI: 10.1016/j.nut.2003.09.011.
J. Chung, A. K. Nguyen, D. C. Henstridge, A. G. Holmes. et al.(2008). HSP72 protects against obesity induced-insulin resistance. Proceedings of the National Academy of Sciences.105(5):1739-1744. DOI: 10.1016/j.nut.2003.09.011.
N. P. Bowles, I. N. Karatsoreos, X Li. (2015). A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome. Proceedings of the National Academy of Sciences.112(1):285-290. DOI: 10.1016/j.nut.2003.09.011.
M. Bensaid, M. Gary-Bobo, A. Esclangon. (2003). The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Molecular Pharmacology.63(4):908-914. DOI: 10.1016/j.nut.2003.09.011.
V. Di Marzo, S. Goparaju, L Wang. (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature.410(6830):822-825. DOI: 10.1016/j.nut.2003.09.011.
V. Castillo, C. Valenzuela, A. M. Ronco, M. Llanos. et al.(2015). Stress during lactation affects fatty acid amide hydrolase protein expression in adipose tissue and liver of adult mice. Endocrinology & Metabolic Syndrome.4(1):1-4. DOI: 10.1016/j.nut.2003.09.011.
D. Cota, G. Marsicano, B. Lutz. (2003). Endogenous cannabinoid system as a modulator of food intake. International Journal of Obesity.27(3):289-301. DOI: 10.1016/j.nut.2003.09.011.
M. Schwartz, R. Seeley, L. Campfield, P. Burn. et al.(1996). Identification of targets of leptin action in rat hypothalamus. Journal of Clinical Investigation.98(5):1101-1106. DOI: 10.1016/j.nut.2003.09.011.
Q. Gao, T. L. Horvath. (2007). Neuronal control of energy homeostasis. FEBS Letters.582(1):132-141. DOI: 10.1016/j.nut.2003.09.011.
C. A. Valenzuela, V. A. Castillo, C. A. Aguirre, A. M. Ronco. et al.(2010). The CB1 receptor antagonist SR141716A reverses adult male mice overweight and metabolic alterations induced by early stress. Obesity.19(1):29-35. DOI: 10.1016/j.nut.2003.09.011.
J. Liu, L. Zhou, K. Xiong. (2012). Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology.142(5):1218-1228. DOI: 10.1016/j.nut.2003.09.011.
C. A. Aguirre, V. A. Castillo, M. N. Llanos. (2012). Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice. Diabetology & Metabolic Syndrome.4(1):35. DOI: 10.1016/j.nut.2003.09.011.
B. V. Beaver, W. Reed, S. Leary. (2001). Report of the AVMA panel on Euthanasia. Journal of the American Veterinary Medical Association.218(5):669-696. DOI: 10.1016/j.nut.2003.09.011.
D. Cota, G. Marsicano, M. Tschöp. (2003). The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. Journal of Clinical Investigation.112(3):423-431. DOI: 10.1016/j.nut.2003.09.011.
C. A. Aguirre, V. A. Castillo, M. N. Llanos. (2015). The endocannabinoid anandamide during lactation increases body fat content and CB1 receptor levels in mice adipose tissue. Nutrition & Diabetes.5(6):167. DOI: 10.1016/j.nut.2003.09.011.
L. Bellocchio, C. Cervino, V. Vicennati, R. Pasquali. et al.(2008). Cannabinoid type 1 receptor: another arrow in the adipocytes’ bow. Journal of Neuroendocrinology.20(1):130-138. DOI: 10.1016/j.nut.2003.09.011.
P. Morigny, M. Houssier, E. Mouisel, D. Langin. et al.(2016). Adipocyte lipolysis and insulin resistance. Biochimie.125:259-266. DOI: 10.1016/j.nut.2003.09.011.
C. Weyer, T. Funahashi, S. Tanaka. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology & Metabolism.86(5):1930-1935. DOI: 10.1016/j.nut.2003.09.011.
A. Loizzo, S. Loizzo, G. Galietta. (2006). Overweight and metabolic and hormonal parameter disruption are induced in adult male mice by manipulations during lactation period. Pediatric Research.59(1):111-115. DOI: 10.1016/j.nut.2003.09.011.
T. Sugiura, S. Kondo, A. Sukagawa. (1995). 2-Arachidonoylgylcerol: a possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications.215(1):89-97. DOI: 10.1016/j.nut.2003.09.011.
I. Kyrou, C. Tsigos. (2007). Stress mechanisms and metabolic complications. Hormone and Metabolic Research.39(6):430-438. DOI: 10.1016/j.nut.2003.09.011.
C. Valenzuela, V. Castillo, A. M. Ronco, C. Aguirre. et al.(2014). A role for the endocannabinoid system in hepatic steatosis. Revista médica de Chile.142(3):353-360. DOI: 10.1016/j.nut.2003.09.011.
J. Freubis, T. Tsao, S Javorschi. (2001). Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA.98(4):2005-2010. DOI: 10.1016/j.nut.2003.09.011.
J. Tam, J. Liu, B. Mukhopadhyay, R. Cinar. et al.(2011). Endocannabinoids in liver disease. Hepatology.53(1):346-355. DOI: 10.1016/j.nut.2003.09.011.
W. A. Devane, A. Breuer, T. Sheskin, T. U. C. Jaerbe. et al.(1992). A novel probe for the cannabinoid receptor. Journal of Medicinal Chemistry.35(11):2065-2069. DOI: 10.1016/j.nut.2003.09.011.
R. A. Waterland, R. L. Jirtle. (2004). Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition.20(1):63-68. DOI: 10.1016/j.nut.2003.09.011.
D. Osei-Hyiaman, M. DePetrillo, P. Pacher. (2005). Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation.115(5):1298-1305. DOI: 10.1016/j.nut.2003.09.011.
A. Lucas. (1991). Programming by early nutrition in man. Ciba Foundation symposium.156:38-55. DOI: 10.1016/j.nut.2003.09.011.
M. Côté, I. Matias, I. Lemieux. (2007). Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. International Journal of Obesity.31(4):692-699. DOI: 10.1016/j.nut.2003.09.011.
M. Bouaboula, S. Hilairet, J. Marchand, L. Fajas. et al.(2005). Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation. European Journal of Pharmacology.517(3):174-181. DOI: 10.1016/j.nut.2003.09.011.
A. Giuffrida, M. Beltramo, D. Piomelli. (2001). Mechanisms of endocannabinoid inactivation:biochemistry and pharmacology. The Journal of Pharmacology and Experimental Therapeutics.298(1):7-14. DOI: 10.1016/j.nut.2003.09.011.
T. Muller, L. Demizieux, S. Troy-Fioramonti. (2017). Overactivation of the endocannabinoid system alters the antilipolytic action of insulin in mouse adipose tissue. American Journal of Physiology-Endocrinology and Metabolism.313(1):26-36. DOI: 10.1016/j.nut.2003.09.011.
M. Maccarrone, E. Dainese, S. Oddi. (2010). Intracellular trafficking of anandamide: new concepts for signaling. Trends in Biochemical Sciences.35(11):601-608. DOI: 10.1016/j.nut.2003.09.011.
D. Osei-Hyiaman, J. Liu, L. Zhou. (2008). Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. Journal of Clinical Investigation.118(9):3160-3169. DOI: 10.1016/j.nut.2003.09.011.
H. Heid, R. Moll, I. Schwetlick, H. Rackwitz. et al.(1998). Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell and Tissue Research.294(2):309-321. DOI: 10.1016/j.nut.2003.09.011.
M. N. Hill, S. Patel, P. Campolongo, J. G. Tasker. et al.(2010). Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. Journal of Neuroscience.30(45):14980-14986. DOI: 10.1016/j.nut.2003.09.011.
Several reports have shown that stress during lactation causes long-term metabolic and hormonal disruptions. In this study, we designed experiments to evaluate the effects of stress during lactation on the abundance of Type 1 cannabinoid/endocannabinoid receptors (CB1R) in epididymal fat and liver and development of insulin resistance in adult mice. During the whole lactation, male mice pups were daily subcutaneously injected (days 1–21) with a saline solution to produce a soft nociceptive stress (NS). Mice body weight and food intake were periodically evaluated. Adult animals were subsequently subjected to an insulin tolerance test and some days later sacrificed to evaluate the amount of epididymal fat and abundance of CB1R and adipophilin in liver and epididymal adipose tissue. Lipoprotein lipase (LPL) activity and circulating levels of leptin, adiponectin, and corticosterone were also evaluated. In this model, NS during lactation significantly increased the amount of epididymal fat and induced insulin resistance in adult mice. In addition, a significantly increased abundance of CB1R and adipophilin in epididymal fat and liver was observed, together with elevated circulating levels of leptin and corticosterone. Adult NS animals also had low plasmatic adiponectin and, although nonsignificant, had a sustained trend to a greater LPL activity associated with epididymal fat. These results indicate that increased abundance of CB1R in liver and epididymal fat alters tissue functionality likely associated with development of systemic metabolic alterations such as insulin resistance in adult mice. All these pathophysiological facts are long-term consequences of nociceptive stress during lactation.

References: V. 

V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.